Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation
- PMID: 2103758
- DOI: 10.1111/j.1365-2036.1990.tb00486.x
Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation
Abstract
The effect of duodenal ulcer healing on the acid secretory responses to modified sham feeding and maximal pentagastrin stimulation has been studied in 17 patients treated successfully with ranitidine (n = 9) and sucralfate (n = 8). Parietal cell sensitivity was calculated as the ratio of the modified sham feeding response to the peak pentagastrin response, expressed as a percentage. Ulcer healing after sucralfate therapy resulted in significant falls in modified sham feeding stimulated acid output (P less than 0.02), from 9.4 (1.8-17.0) (median + range) to 3.7 (0.2-9.4) mmol/h; in peak acid output (P less than 0.05) from 42.8 (23.0-61.4) to 27.7 (7.2-51.0) mmol/h; and in the parietal cell sensitivity (P less than 0.05) from 19.2 (4.4-42.6) to 14.3 (2.8-19.7)%. No significant falls in any of these parameters were noted following ulcer healing with ranitidine. Duodenal ulcer healing with sucralfate results in decreased acid secretory responses to vagal and pentagastrin stimulation.
Similar articles
-
Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.Gut. 1992 Feb;33(2):175-8. doi: 10.1136/gut.33.2.175. Gut. 1992. PMID: 1541412 Free PMC article.
-
Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.Am J Med. 1991 Aug 8;91(2A):91S-94S. doi: 10.1016/0002-9343(91)90457-9. Am J Med. 1991. PMID: 1882910 Clinical Trial.
-
Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.Am J Med. 1991 Aug 8;91(2A):95S-101S. doi: 10.1016/0002-9343(91)90458-a. Am J Med. 1991. PMID: 1882911 Review.
-
Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine.Am J Med. 1989 Jun 9;86(6A):145-7. doi: 10.1016/0002-9343(89)90177-0. Am J Med. 1989. PMID: 2735330 Clinical Trial.
-
The developmental physiology of the stomach: possible contributions to the regulatory disturbances of duodenal ulcer disease.Proc Soc Exp Biol Med. 1984 Feb;175(2):119-26. doi: 10.3181/00379727-175-41777. Proc Soc Exp Biol Med. 1984. PMID: 6141567 Review.
Cited by
-
Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.Gut. 1992 Feb;33(2):175-8. doi: 10.1136/gut.33.2.175. Gut. 1992. PMID: 1541412 Free PMC article.
-
Helicobacter pylori eradication, duodenal ulcer healing, and gastric secretory state.Gut. 1994 Apr;35(4):571. doi: 10.1136/gut.35.4.571. Gut. 1994. PMID: 8175003 Free PMC article. No abstract available.
-
The H2-receptor antagonist era in duodenal ulcer disease.Yale J Biol Med. 1992 Nov-Dec;65(6):639-48;discussion 689-92. Yale J Biol Med. 1992. PMID: 1364125 Free PMC article. Review.
-
Optimizing acid suppression for treatment of acid-related diseases.Dig Dis Sci. 1995 Feb;40(2 Suppl):24S-49S. doi: 10.1007/BF02214870. Dig Dis Sci. 1995. PMID: 7859582 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources